BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $203,435 | -10.7% | 4,465 | -0.1% | 0.02% | -21.7% |
| Q4 2022 | $227,795 | -99.9% | 4,469 | -1.0% | 0.02% | -14.8% |
| Q3 2022 | $243,081,000 | -16.4% | 4,513 | -0.3% | 0.03% | -15.6% |
| Q2 2022 | $290,654,000 | -17.2% | 4,525 | -0.0% | 0.03% | -3.0% |
| Q1 2022 | $351,040,000 | -10.0% | 4,527 | -0.4% | 0.03% | -8.3% |
| Q4 2021 | $390,161,000 | +6.6% | 4,545 | -0.1% | 0.04% | +2.9% |
| Q3 2021 | $365,973,000 | -0.7% | 4,550 | -0.6% | 0.04% | -2.8% |
| Q2 2021 | $368,536,000 | -6.2% | 4,578 | -1.7% | 0.04% | -10.0% |
| Q1 2021 | $392,856,000 | +3.6% | 4,658 | -1.4% | 0.04% | -7.0% |
| Q4 2020 | $379,288,000 | -2.6% | 4,726 | -2.3% | 0.04% | -12.2% |
| Q3 2020 | $389,220,000 | -14.0% | 4,839 | -7.9% | 0.05% | -21.0% |
| Q2 2020 | $452,349,000 | -13.2% | 5,253 | -11.8% | 0.06% | -1.6% |
| Q3 2019 | $520,845,000 | +4.3% | 5,953 | -2.4% | 0.06% | +1.6% |
| Q2 2019 | $499,558,000 | +7.5% | 6,099 | +6.7% | 0.06% | -1.6% |
| Q1 2019 | $464,631,000 | +16.2% | 5,714 | -5.9% | 0.06% | +5.0% |
| Q4 2018 | $399,788,000 | -8.2% | 6,073 | +7.6% | 0.06% | 0.0% |
| Q3 2018 | $435,303,000 | -2.0% | 5,646 | -6.1% | 0.06% | -6.2% |
| Q2 2018 | $444,102,000 | +376257.6% | 6,014 | +231.7% | 0.06% | +255.6% |
| Q1 2018 | $118,000 | -43.0% | 1,813 | -39.9% | 0.02% | -61.7% |
| Q1 2015 | $207,000 | -23.0% | 3,017 | -19.1% | 0.05% | -26.6% |
| Q2 2014 | $269,000 | +8.0% | 3,727 | +10.2% | 0.06% | -4.5% |
| Q1 2014 | $249,000 | +21.5% | 3,381 | -1.7% | 0.07% | +4.7% |
| Q2 2011 | $205,000 | – | 3,438 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |